{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:41:21Z","timestamp":1772602881390,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10067-024-07088-y","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T19:02:34Z","timestamp":1722538954000},"page":"2867-2875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics and risk factors for lupus flares in sub-Saharan Africa-retrospective cross-sectional study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8326-8875","authenticated-orcid":false,"given":"Biruk Abate","family":"Legesse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-4516","authenticated-orcid":false,"given":"Becky Abdissa","family":"Adugna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6025-8619","authenticated-orcid":false,"given":"Zekarias Seifu","family":"Ayalew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6849-1293","authenticated-orcid":false,"given":"Gebeyehu Tessema","family":"Azibte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6447-2165","authenticated-orcid":false,"given":"Seid Ibrahim","family":"Abdulkadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8045-441X","authenticated-orcid":false,"given":"Biruktawit Adebabay","family":"Mengist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0325-966X","authenticated-orcid":false,"given":"Daniel Andualem","family":"Zewde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3223-8267","authenticated-orcid":false,"given":"Amhha Zewdu","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9485-7248","authenticated-orcid":false,"given":"Berhanu Moges","family":"Abera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3748-6532","authenticated-orcid":false,"given":"Aron Berhanu","family":"Gudetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"issue":"9","key":"7088_CR1","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3899\/jrheum.091443","volume":"37","author":"M Jolly","year":"2010","unstructured":"Jolly M et al (2010) LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol 37(9):1828\u20131833. https:\/\/doi.org\/10.3899\/jrheum.091443","journal-title":"J Rheumatol"},{"issue":"1","key":"7088_CR2","doi-asserted-by":"publisher","first-page":"e000078","DOI":"10.1136\/lupus-2014-000078","volume":"2","author":"A Fayyaz","year":"2015","unstructured":"Fayyaz A et al (2015) Haematological manifestations of lupus. Lupus Sci Med 2(1):e000078. https:\/\/doi.org\/10.1136\/lupus-2014-000078","journal-title":"Lupus Sci Med"},{"issue":"6","key":"7088_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/art.1780380617","volume":"38","author":"PS McKinley","year":"1995","unstructured":"McKinley PS, Ouellette SC, Winkel GH (1995) The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model. Arthritis Rheum 38(6):826\u2013834. https:\/\/doi.org\/10.1002\/art.1780380617","journal-title":"Arthritis Rheum"},{"issue":"10","key":"7088_CR4","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/art.40191","volume":"69","author":"M Dall'Era","year":"2017","unstructured":"Dall\u2019Era M et al (2017) The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project. Arthritis Rheumatol 69(10):1996\u20132005. https:\/\/doi.org\/10.1002\/art.40191","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"7088_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber MRW et al (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17(9):515\u2013532. https:\/\/doi.org\/10.1038\/s41584-021-00668-1","journal-title":"Nat Rev Rheumatol"},{"key":"7088_CR6","doi-asserted-by":"publisher","first-page":"102348","DOI":"10.1016\/j.jaut.2019.102348","volume":"106","author":"M Essouma","year":"2020","unstructured":"Essouma M et al (2020) Systemic lupus erythematosus in Native sub-Saharan Africans: a systematic review and meta-analysis. J Autoimmun 106:102348. https:\/\/doi.org\/10.1016\/j.jaut.2019.102348","journal-title":"J Autoimmun"},{"issue":"8","key":"7088_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/art.1780340802","volume":"34","author":"M Petri","year":"1991","unstructured":"Petri M et al (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34(8):937\u2013944. https:\/\/doi.org\/10.1002\/art.1780340802","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7088_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630\u201340. https:\/\/doi.org\/10.1002\/art.1780350606","journal-title":"Arthritis Rheum"},{"key":"7088_CR9","doi-asserted-by":"publisher","unstructured":"Hao Y et al (2022) Flare rates and factors determining flare occurrence in patients with systemic lupus erythematosus who achieved low disease activity or remission: results from a prospective cohort study. Lupus Sci Med 9(1). https:\/\/doi.org\/10.1136\/lupus-2021-000553","DOI":"10.1136\/lupus-2021-000553"},{"issue":"2","key":"7088_CR10","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288\u2013291","journal-title":"J Rheumatol"},{"issue":"5","key":"7088_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/0961203310388445","volume":"20","author":"N Ruperto","year":"2011","unstructured":"Ruperto N et al (2011) International consensus for a definition of disease flare in lupus. Lupus 20(5):453\u2013462. https:\/\/doi.org\/10.1177\/0961203310388445","journal-title":"Lupus"},{"issue":"1","key":"7088_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.31138\/mjr.28.1.4\/","volume":"28","author":"C Adamichou","year":"2017","unstructured":"Adamichou C, Bertsias G (2017) Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol 28(1):4\u201312. https:\/\/doi.org\/10.31138\/mjr.28.1.4\/","journal-title":"Mediterr J Rheumatol"},{"issue":"11","key":"7088_CR13","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/keg382","volume":"42","author":"C Gordon","year":"2003","unstructured":"Gordon C et al (2003) Definition and treatment of lupus flares measured by the BILAG index. Rheumatology (Oxford) 42(11):1372\u20131379. https:\/\/doi.org\/10.1093\/rheumatology\/keg382","journal-title":"Rheumatology (Oxford)"},{"issue":"24","key":"7088_CR14","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa051135","volume":"353","author":"M Petri","year":"2005","unstructured":"Petri M et al (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353(24):2550\u20132558. https:\/\/doi.org\/10.1056\/NEJMoa051135","journal-title":"N Engl J Med"},{"issue":"12","key":"7088_CR15","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1093\/rheumatology\/keu274","volume":"53","author":"JE Pope","year":"2014","unstructured":"Pope JE (2014) Measuring flares in systemic lupus erythematosus. Rheumatology (Oxford) 53(12):2134\u20132135. https:\/\/doi.org\/10.1093\/rheumatology\/keu274","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"7088_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.autrev.2013.11.007","volume":"13","author":"R Cervera","year":"2014","unstructured":"Cervera R et al (2014) Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev 13(6):621\u2013629. https:\/\/doi.org\/10.1016\/j.autrev.2013.11.007","journal-title":"Autoimmun Rev"},{"issue":"9","key":"7088_CR17","doi-asserted-by":"publisher","first-page":"e45934","DOI":"10.1371\/journal.pone.0045934","volume":"7","author":"F Conti","year":"2012","unstructured":"Conti F et al (2012) Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up study. PLoS One 7(9):e45934. https:\/\/doi.org\/10.1371\/journal.pone.0045934","journal-title":"PLoS One"},{"key":"7088_CR18","doi-asserted-by":"publisher","unstructured":"Cornet A et al (2021) Living with systemic lupus erythematosus in 2020: a European patient survey. Lupus Sci Med 8(1). https:\/\/doi.org\/10.1136\/lupus-2020-000469","DOI":"10.1136\/lupus-2020-000469"},{"issue":"1","key":"7088_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.55563\/clinexprheumatol\/x3s9td","volume":"41","author":"NN Kapsala","year":"2023","unstructured":"Kapsala NN et al (2023) From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study. Clin Exp Rheumatol 41(1):74\u201381. https:\/\/doi.org\/10.55563\/clinexprheumatol\/x3s9td","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"7088_CR20","doi-asserted-by":"publisher","first-page":"rkaa011","DOI":"10.1093\/rap\/rkaa011","volume":"4","author":"F Bongomin","year":"2020","unstructured":"Bongomin F, Sekimpi M, Kaddumukasa M (2020) Clinical and immunological characteristics of 56 patients with systemic lupus erythematosus in Uganda. Rheumatol Adv Pract 4(1):rkaa011. https:\/\/doi.org\/10.1093\/rap\/rkaa011","journal-title":"Rheumatol Adv Pract"},{"issue":"8","key":"7088_CR21","first-page":"1180","volume":"67","author":"A Khan","year":"2017","unstructured":"Khan A et al (2017) Clinical manifestations of patients with Systemic Lupus Erythematosus (SLE) in Khyber Pakhtunkhwa. J Pak Med Assoc 67(8):1180\u20131185","journal-title":"J Pak Med Assoc"},{"issue":"11","key":"7088_CR22","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/0961203313499086","volume":"22","author":"M Li","year":"2013","unstructured":"Li M et al (2013) Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus. Lupus 22(11):1192\u20139. https:\/\/doi.org\/10.1177\/0961203313499086","journal-title":"Lupus"},{"key":"7088_CR23","doi-asserted-by":"publisher","unstructured":"Gergianaki I et al (2021) High comorbidity burden in patients with SLE: data from the community-based lupus registry of Crete. J Clin Med 10(5). https:\/\/doi.org\/10.3390\/jcm10050998","DOI":"10.3390\/jcm10050998"},{"key":"7088_CR24","doi-asserted-by":"publisher","first-page":"1118390","DOI":"10.3389\/fmed.2023.1118390","volume":"10","author":"KMS Al-Arbi","year":"2023","unstructured":"Al-Arbi KMS, Magula NP, Mody GM (2023) Tuberculosis remains a major burden in systemic lupus erythematosus patients in Durban, South Africa. Front Med (Lausanne) 10:1118390. https:\/\/doi.org\/10.3389\/fmed.2023.1118390","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"7088_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41927-023-00333-y","volume":"7","author":"A Fatemi","year":"2023","unstructured":"Fatemi A, Keivani-Boroujeni E, Smiley A (2023) Predictors of severe lupus flare: a prospective follow-up study. BMC Rheumatol 7(1):10. https:\/\/doi.org\/10.1186\/s41927-023-00333-y","journal-title":"BMC Rheumatol"},{"issue":"1","key":"7088_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/rheumatology\/ket322","volume":"53","author":"L In\u00eas","year":"2014","unstructured":"In\u00eas L et al (2014) Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study. Rheumatology (Oxford) 53(1):85\u201389. https:\/\/doi.org\/10.1093\/rheumatology\/ket322","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"7088_CR27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/rheumatology\/kez422","volume":"59","author":"M Zen","year":"2020","unstructured":"Zen M et al (2020) Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission. Rheumatology (Oxford) 59(7):1591\u20131598. https:\/\/doi.org\/10.1093\/rheumatology\/kez422","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07088-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T09:11:38Z","timestamp":1723885898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07088-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["7088"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07088-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted by the Declaration of Helsinki and approved by the Institutional Review Board of Addis Ababa University, College of Medicine and Health Sciences protocol number 9923 on 26\/08\/2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed written and verbal consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare they have no competing interests to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}